Back to Search
FRANCES COLLICHIO, MD
MD
Hematology & Oncology Physician
NPI: 1841363595IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
Education
UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY
Class of 1987
Research & Publications (12)
Developing an in-training examination for fellows: the experience of the American Society of Clinical Oncology.
PMID 19224843·J Clin Oncol·2009
8-other
Phase II study of low-dose infusional 5-fluorouracil and paclitaxel (Taxol) given every 2 weeks in metastatic breast cancer.
PMID 11943902·Am J Clin Oncol·2002
3-trial
A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors.
PMID 18327587·Cancer Chemother Pharmacol·2008
3-trial
The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
PMID 17438091·Clin Cancer Res·2007
8-other
Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane) on three treatment schedules in patients with solid tumors.
PMID 17285317·Cancer Chemother Pharmacol·2007
3-trial
Response and cardiac toxicity of trastuzumab given in conjunction with weekly paclitaxel after doxorubicin/cyclophosphamide.
PMID 16942640·Clin Breast Cancer·2006
3-trial
Axillary lymph node count is lower after neoadjuvant chemotherapy.
PMID 16720159·Am J Surg·2006
4-observational
Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer.
PMID 17012048·Lancet Oncol·2006
6-review
American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome.
PMID 16077072·J Natl Cancer Inst·2005
8-other
High-resolution axillary ultrasound is a poor prognostic test for determining pathologic lymph node status in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer.
PMID 15474431·Am J Surg·2004
8-other
Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer.
PMID 15185007·Cancer Immunol Immunother·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 101 MANNING DR
CHAPEL HILL, NC 27599 - Phone
- (919) 966-4996
Quick Facts
- NPI
- 1841363595
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 12
Are you this provider?
Claim Your Profile